The U.S. Food and Drug Administration has approved the Zycubo (copper histidinate) injection as the first treatment for ...
Britain's GSK has agreed to buy RAPT Therapeutics for $2.2 billion, accessing the U.S. biotech's experimental drug to treat ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results